Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and 伪-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The global Apomorphine Hydrochloride market is projected to grow from US$ 289.5 million in 2024 to US$ 364.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.9% during the forecast period.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.
Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.
Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.
麻豆原创 competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Report Covers:
This report presents an overview of global market for Apomorphine Hydrochloride, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Apomorphine Hydrochloride, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Apomorphine Hydrochloride, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Apomorphine Hydrochloride sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Apomorphine Hydrochloride market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Apomorphine Hydrochloride sales, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Ever Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion
Segment by Type
Injection
Tablets
Thinfilm
Nasal Powder (Pipeline)
Segment by Application
Parkinson Disease
Erectile Dysfunction
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Apomorphine Hydrochloride in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Apomorphine Hydrochloride manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Apomorphine Hydrochloride sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Apomorphine Hydrochloride Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Apomorphine Hydrochloride 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Injection
1.2.3 Tablets
1.2.4 Thinfilm
1.2.5 Nasal Powder (Pipeline)
1.3 麻豆原创 by Application
1.3.1 Global Apomorphine Hydrochloride 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Parkinson Disease
1.3.3 Erectile Dysfunction
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Apomorphine Hydrochloride Sales Estimates and Forecasts 2019-2030
2.2 Global Apomorphine Hydrochloride Revenue by Region
2.2.1 Global Apomorphine Hydrochloride Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Apomorphine Hydrochloride Revenue by Region (2019-2024)
2.2.3 Global Apomorphine Hydrochloride Revenue by Region (2025-2030)
2.2.4 Global Apomorphine Hydrochloride Revenue 麻豆原创 Share by Region (2019-2030)
2.3 Global Apomorphine Hydrochloride Sales Estimates and Forecasts 2019-2030
2.4 Global Apomorphine Hydrochloride Sales by Region
2.4.1 Global Apomorphine Hydrochloride Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Apomorphine Hydrochloride Sales by Region (2019-2024)
2.4.3 Global Apomorphine Hydrochloride Sales by Region (2025-2030)
2.4.4 Global Apomorphine Hydrochloride Sales 麻豆原创 Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Apomorphine Hydrochloride Sales by Manufacturers
3.1.1 Global Apomorphine Hydrochloride Sales by Manufacturers (2019-2024)
3.1.2 Global Apomorphine Hydrochloride Sales 麻豆原创 Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Apomorphine Hydrochloride in 2023
3.2 Global Apomorphine Hydrochloride Revenue by Manufacturers
3.2.1 Global Apomorphine Hydrochloride Revenue by Manufacturers (2019-2024)
3.2.2 Global Apomorphine Hydrochloride Revenue 麻豆原创 Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Apomorphine Hydrochloride Revenue in 2023
3.3 Global Key Players of Apomorphine Hydrochloride, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Apomorphine Hydrochloride Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers 麻豆原创 Concentration Ratio (CR5 and HHI)
3.5.2 Global Apomorphine Hydrochloride 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Apomorphine Hydrochloride, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Apomorphine Hydrochloride, Product Offered and Application
3.8 Global Key Manufacturers of Apomorphine Hydrochloride, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 麻豆原创 Size by Type
4.1 Global Apomorphine Hydrochloride Sales by Type
4.1.1 Global Apomorphine Hydrochloride Historical Sales by Type (2019-2024)
4.1.2 Global Apomorphine Hydrochloride Forecasted Sales by Type (2025-2030)
4.1.3 Global Apomorphine Hydrochloride Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Apomorphine Hydrochloride Revenue by Type
4.2.1 Global Apomorphine Hydrochloride Historical Revenue by Type (2019-2024)
4.2.2 Global Apomorphine Hydrochloride Forecasted Revenue by Type (2025-2030)
4.2.3 Global Apomorphine Hydrochloride Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Apomorphine Hydrochloride Price by Type
4.3.1 Global Apomorphine Hydrochloride Price by Type (2019-2024)
4.3.2 Global Apomorphine Hydrochloride Price Forecast by Type (2025-2030)
5 麻豆原创 Size by Application
5.1 Global Apomorphine Hydrochloride Sales by Application
5.1.1 Global Apomorphine Hydrochloride Historical Sales by Application (2019-2024)
5.1.2 Global Apomorphine Hydrochloride Forecasted Sales by Application (2025-2030)
5.1.3 Global Apomorphine Hydrochloride Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Apomorphine Hydrochloride Revenue by Application
5.2.1 Global Apomorphine Hydrochloride Historical Revenue by Application (2019-2024)
5.2.2 Global Apomorphine Hydrochloride Forecasted Revenue by Application (2025-2030)
5.2.3 Global Apomorphine Hydrochloride Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Apomorphine Hydrochloride Price by Application
5.3.1 Global Apomorphine Hydrochloride Price by Application (2019-2024)
5.3.2 Global Apomorphine Hydrochloride Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Apomorphine Hydrochloride 麻豆原创 Size by Type
6.1.1 US & Canada Apomorphine Hydrochloride Sales by Type (2019-2030)
6.1.2 US & Canada Apomorphine Hydrochloride Revenue by Type (2019-2030)
6.2 US & Canada Apomorphine Hydrochloride 麻豆原创 Size by Application
6.2.1 US & Canada Apomorphine Hydrochloride Sales by Application (2019-2030)
6.2.2 US & Canada Apomorphine Hydrochloride Revenue by Application (2019-2030)
6.3 US & Canada Apomorphine Hydrochloride 麻豆原创 Size by Country
6.3.1 US & Canada Apomorphine Hydrochloride Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Apomorphine Hydrochloride Sales by Country (2019-2030)
6.3.3 US & Canada Apomorphine Hydrochloride Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Apomorphine Hydrochloride 麻豆原创 Size by Type
7.1.1 Europe Apomorphine Hydrochloride Sales by Type (2019-2030)
7.1.2 Europe Apomorphine Hydrochloride Revenue by Type (2019-2030)
7.2 Europe Apomorphine Hydrochloride 麻豆原创 Size by Application
7.2.1 Europe Apomorphine Hydrochloride Sales by Application (2019-2030)
7.2.2 Europe Apomorphine Hydrochloride Revenue by Application (2019-2030)
7.3 Europe Apomorphine Hydrochloride 麻豆原创 Size by Country
7.3.1 Europe Apomorphine Hydrochloride Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Apomorphine Hydrochloride Sales by Country (2019-2030)
7.3.3 Europe Apomorphine Hydrochloride Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Apomorphine Hydrochloride 麻豆原创 Size
8.1.1 China Apomorphine Hydrochloride Sales (2019-2030)
8.1.2 China Apomorphine Hydrochloride Revenue (2019-2030)
8.2 China Apomorphine Hydrochloride 麻豆原创 Size by Application
8.2.1 China Apomorphine Hydrochloride Sales by Application (2019-2030)
8.2.2 China Apomorphine Hydrochloride Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Apomorphine Hydrochloride 麻豆原创 Size by Type
9.1.1 Asia Apomorphine Hydrochloride Sales by Type (2019-2030)
9.1.2 Asia Apomorphine Hydrochloride Revenue by Type (2019-2030)
9.2 Asia Apomorphine Hydrochloride 麻豆原创 Size by Application
9.2.1 Asia Apomorphine Hydrochloride Sales by Application (2019-2030)
9.2.2 Asia Apomorphine Hydrochloride Revenue by Application (2019-2030)
9.3 Asia Apomorphine Hydrochloride Sales by Region
9.3.1 Asia Apomorphine Hydrochloride Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Apomorphine Hydrochloride Revenue by Region (2019-2030)
9.3.3 Asia Apomorphine Hydrochloride Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Apomorphine Hydrochloride 麻豆原创 Size by Type
10.1.1 Middle East, Africa and Latin America Apomorphine Hydrochloride Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Apomorphine Hydrochloride Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Apomorphine Hydrochloride 麻豆原创 Size by Application
10.2.1 Middle East, Africa and Latin America Apomorphine Hydrochloride Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Apomorphine Hydrochloride Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Apomorphine Hydrochloride Sales by Country
10.3.1 Middle East, Africa and Latin America Apomorphine Hydrochloride Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Apomorphine Hydrochloride Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Apomorphine Hydrochloride Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Supernus Pharmaceuticals
11.1.1 Supernus Pharmaceuticals Company Information
11.1.2 Supernus Pharmaceuticals Overview
11.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Supernus Pharmaceuticals Recent Developments
11.2 Britannia Pharmaceuticals STADA
11.2.1 Britannia Pharmaceuticals STADA Company Information
11.2.2 Britannia Pharmaceuticals STADA Overview
11.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Britannia Pharmaceuticals STADA Recent Developments
11.3 Ever Pharma
11.3.1 Ever Pharma Company Information
11.3.2 Ever Pharma Overview
11.3.3 Ever Pharma Apomorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Ever Pharma Apomorphine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Ever Pharma Recent Developments
11.4 Evolan Pharma AB (PharmSwed)
11.4.1 Evolan Pharma AB (PharmSwed) Company Information
11.4.2 Evolan Pharma AB (PharmSwed) Overview
11.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Evolan Pharma AB (PharmSwed) Recent Developments
11.5 Tianjin Tianwei Pharmaceutical
11.5.1 Tianjin Tianwei Pharmaceutical Company Information
11.5.2 Tianjin Tianwei Pharmaceutical Overview
11.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tianjin Tianwei Pharmaceutical Recent Developments
11.6 Sunovion
11.6.1 Sunovion Company Information
11.6.2 Sunovion Overview
11.6.3 Sunovion Apomorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Sunovion Apomorphine Hydrochloride Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sunovion Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Apomorphine Hydrochloride Industry Chain Analysis
12.2 Apomorphine Hydrochloride Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Apomorphine Hydrochloride Production Mode & Process
12.4 Apomorphine Hydrochloride Sales and 麻豆原创ing
12.4.1 Apomorphine Hydrochloride Sales Channels
12.4.2 Apomorphine Hydrochloride Distributors
12.5 Apomorphine Hydrochloride Customers
13 麻豆原创 Dynamics
13.1 Apomorphine Hydrochloride Industry Trends
13.2 Apomorphine Hydrochloride 麻豆原创 Drivers
13.3 Apomorphine Hydrochloride 麻豆原创 Challenges
13.4 Apomorphine Hydrochloride 麻豆原创 Restraints
14 Key Findings in The Global Apomorphine Hydrochloride Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion
听
听
*If Applicable.